SONG Zhongyang,YONG Wenxing,LI Juan,et al.Analysis on TCM Syndrome Rules of 60 Cases of Novel Coronavirus Pneumonia in Gansu Area[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):29-33.[doi:10.3969/j.issn.1005-5304.202002569]
甘肃地区60例普通型新型冠状病毒肺炎患者中医证候规律分析
- Title:
- Analysis on TCM Syndrome Rules of 60 Cases of Novel Coronavirus Pneumonia in Gansu Area
- 文章编号:
- 1005-5304(2020)07-0029-05
- Keywords:
- novel coronavirus pneumonia; common type; Gansu area; TCM; syndrome rules
- 分类号:
- R259.11
- 文献标志码:
- A
- 摘要:
- 目的 探讨甘肃地区普通型新型冠状病毒肺炎（COVID-19）患者中医证候特点，为中医干预和辨证论治提供参考。方法 采用中医证候量表收集甘肃地区60例普通型COVID-19患者基本信息、中医症状、体征、舌象、脉象、中医证型，采用描述性分析和聚类分析方法，观察不同性别、年龄、发病时间的COVID-19患者的中医证候特点，分析其病机演变规律。结果 60 例患者中医临床症状频数高低依次为咳嗽、发热、咳痰、乏力、肌肉酸痛、气短、胸闷憋气、咽痛、咽干、口渴、头痛。舌质主要见淡红舌、红舌和黯红舌；舌苔主要见黄腻苔、白腻苔、薄白苔；脉象主要见滑脉、濡脉、浮脉。中医证型频数高低依次为湿热郁肺证、寒湿犯肺证、湿热并重证、热毒闭肺证、肺脾气虚证、温邪犯肺证、湿毒血瘀证。男性患者以湿热郁肺证、寒湿犯肺证为主，女性患者以寒湿犯肺证、湿热并重证较为常见。20～29岁患者以寒湿犯肺证为主，30～49岁以湿热郁肺证、湿热并重证较多，50～59岁以肺脾气虚证为主。发病时间＜3 d者，以寒湿犯肺证多见，3～7 d者以湿热郁肺证、湿热并重证较为多见，＞7 d者以热毒闭肺证、肺脾气虚证为主。结论 甘肃地区普通型COVID-19患者中医证候分布具有一定规律性，60例普通型COVID-19患者中，湿热郁肺证最为常见，其次为寒湿犯肺证、湿热并重证、热毒闭肺证、肺脾气虚证等。不同性别、年龄、发病时间的患者中医证候存在差异性，其病机演变为寒湿向热郁夹湿、热毒进展，后期出现肺脾气虚。
- Abstract:
- Objective To explore characteristics of TCM syndromes of patients with novel coronavirus pneumonia (COVID-19) in Gansu area; To provide references for TCM intervention and syndrome differentiation. Methods Totally 60 cases of common COVID-19 patients in Gansu area were collected by TCM syndrome scale, and their basic information, TCM symptoms, signs, tongue, pulse and syndrome types were analyzed by descriptive analysis and cluster analysis. The characteristics of TCM syndromes of COVID-19 patients of different genders, ages, and course of disease were observed, and the evolution of the pathogenesis was analyzed. Results TCM clinical symptoms of 60 COVID-19 patients from high to low were cough, fever, expectoration, asthenia, muscle ache, shortness of breath, chest tightness and suffocation, pharyngeal pain, pharyngeal dryness, thirst, headache. Tongue was mainly seen in light red tongue, red tongue and dark red tongue; tongue coating was mainly seen in yellow greasy coating, white thick coating and thin white coating; pulse was mostly seen in slippery pulse, soft pulse and floating pulse. According to the frequency, TCM syndrome types were damp heat stagnation in the lung syndrome, cold dampness invading lung syndrome, heat and dampness combined syndrome, heat toxin closing the lung syndrome, deficiency of lung-spleen qi syndrome, warm pathogen attacking the lung syndrome, damp toxin and blood stasis syndrome. The syndrome types of male patients were mainly damp heat stagnation in the lung syndrome and cold dampness invading lung syndrome; the female patients were more common in cold dampness invading lung syndrome and heat and dampness combined syndrome. The TCM syndrome types of the patients aged 20–29 years old were mainly cold dampness invading lung syndrome; 30–49 years old were mainly damp heat stagnation in the lung syndrome and heat and dampness combined syndrome; 50–59 years old were mainly deficiency of lung-spleen qi syndrome. When the course of disease was shorter than 3 d, the syndrome was mainly cold dampness invading lung; when the course of disease was 3–7 d, the syndromes were mainly damp heat stagnation in the lung and heat and dampness combined; when the course of disease was longer than 7 d, the syndromes were mainly heat toxin closing the lung and deficiency of lung-spleen qi. Conclusion The distribution of TCM syndromes of patients with common COVID-19 in Gansu area has certain regularity. Among the 60 cases of COVID-19, damp heat stagnation in the lung syndrome is the most common syndrome, followed by cold dampness invading lung syndrome, heat and dampness combined syndrome, heat toxin closing the lung syndrome, and deficiency of lung qi and spleen syndrome. Different genders, ages and courses of disease also have differences in TCM syndromes, the pathogenesis of which has evolved from cold dampness to heat stagnation with dampness and heat toxin, and deficiency of lung-spleen qi may appear in later stage of the disease.
参考文献/References:
[1] 国家卫生健康委员会.截至2月25日24时新型冠状病毒感染的肺炎疫情最新情况[EB/OL].(2020-02-25)[2020-02-26].http://www.nhc.gov.
cn/xcs/yqfkdt/202002/741ce06130284a77bfbf699483c0fb60.shtml.
[2] 甘肃省卫生健康委员会.我省发现首例新型冠状病毒感染的肺炎疑似病例[EB/OL].(2020-01-23)[2020-02-26].http://wsjk.gansu.gov.cn/ single/10910/82938.html. [3] 甘肃省卫生健康委员会.有效防治新冠肺炎“甘肃方剂”[EB/OL]. (2020-02-15)[2020-02-26].https://new.qq.com/omn/20200216/
20200216A04FZ100.html.
[4] 甘肃省卫生健康委员会.截至2月25日20时新型冠状病毒感染的肺炎疫情最新情况[EB/OL].(2020-02-25)[2020-02-26].http://wsjk. gansu.gov.cn/single/10910/84437.html. [5] 国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-22)[2020-02-26].http://www.nhc. gov.cn/yzygj/s7653p/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtm. [6] 国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第四版)的通知[EB/OL].(2020-01-27)[2020-02-26].http://www.nhc.gov.cn/ yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67.shtml. [7] 国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第五版修正版)的通知[EB/OL].(2020-02-08)[2020-02-26].http://www.nhc.gov. cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml. [8] 国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL].(2020-02-18)[2020-02-26].http://www.nhc.gov.cn/ yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. [9] 甘肃省卫生健康委员会.关于印发甘肃省新型冠状病毒感染的肺炎中医药防治方案(试行第二版)的通知[EB/OL].(2020-02-01)[2020-02-26]. http://wsjk.gansu.gov.cn/file.jsp?contentId=83488. [10] 陈远彬,林杏华,林琳,等.92例流感病毒性肺炎住院患者的中医证候分析[J].中华中医药杂志,2016,31(6)：2342-2344. [11] 孙宏源,毕颖斐,朱振刚,等.天津地区88例新型冠状病毒肺炎患者中医证候特征初探[J/OL].(2020-02-24)[2020-02-26].中医杂志. http://kns.cnki.net/kcms/detail/11.2166.R.20200224.0948.004.html. [12] 杨家耀,苏文,乔杰,等.90例普通型新型冠状病毒肺炎患者中医证候与体质分析[J/OL].(2020-02-23)[2020-02-26].中医杂志.http://kns. cnki.net/kcms/detail/11.2166.R.20200221.1513.004.html. [13] 徐波,范存愈,邹义龙,等.46例新型冠状病毒病中医证候学分析[J/OL].(2020-02-25)[2020-02-26].中国实验方剂学杂志.https:// doi.org/10.13422/j.cnki.syfjx.20201029.
相似文献/References:
[1]龚新月,魏大荣,龚雪,等.重庆市万州区80例新型冠状病毒肺炎患者临床特征及证治分析[J].中国中医药信息杂志,2020,27(7):24.[doi:10.3969/j.issn.1005-5304.202002560]
GONG Xinyue,WEI Darong,GONG Xue,et al.Analysis on Clinical Characteristics and TCM Syndromes of 80 Patients with Novel Coronavirus Pneumonia in Wanzhou District of Chongqing[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):24.[doi:10.3969/j.issn.1005-5304.202002560]
[2]田伟,刘赓,张晓颖,等.新型冠状病毒肺炎中西医结合呼吸康复方案（草案）[J].中国中医药信息杂志,2020,27(8):1.[doi:10.3969/j.issn.1005-5304.202002433]
TIAN Wei,LIU Geng,ZHANG Xiaoying,et al.Respiratory Rehabilitation Program (Draft) of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19)[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):1.[doi:10.3969/j.issn.1005-5304.202002433]
[3]鹿振辉,邱磊,张少言,等.试论新型冠状病毒肺炎重症“寒湿水饮闭肺，命门之火不振”之变[J].中国中医药信息杂志,2020,27(8):15.[doi:10.3969/j.issn.1005-5304.202002161]
LU Zhenhui,QIU Lei,ZHANG Shaoyan,et al.Discussion on the Change of Cold-dampness and Retained Fluid Blocking Lung with Fire Deficiency of Mingmen (the gate of life) in Severe Patients with Coronavirus Disease 2019[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):15.[doi:10.3969/j.issn.1005-5304.202002161]
[4]王进忠,谢文源,覃小兰,等.基于文献探讨膜原学说在新型冠状病毒肺炎中的临床应用[J].中国中医药信息杂志,2020,27(9):21.[doi:10.3969/j.issn.1005-5304.202002354]
WANG Jinzhong,XIE Wenyuan,QIN Xiaolan,et al.Clinical Application of Moyuan Theory in Coronavirus Disease 2019 Based on Literature Reports[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):21.[doi:10.3969/j.issn.1005-5304.202002354]
[5]周红光.试论新型冠状病毒肺炎中医药防治[J].中国中医药信息杂志,2020,27(9):25.[doi:10.3969/j.issn.1005-5304.202002171]
ZHOU Hongguang.Discussion on Prevention and Treatment of Coronavirus Disease 2019 with TCM[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):25.[doi:10.3969/j.issn.1005-5304.202002171]
[6]魏本君,王庆胜,雍文兴,等.甘肃新型冠状病毒肺炎特征及中医治疗[J].中国中医药信息杂志,2020,27(10):13.[doi:10.19879/j.cnki.1005-5304.202002233]
WEI Benjun,WANG Qingsheng,YONG Wenxing,et al.Characteristics of Novel Coronavirus Pneumonia and TCM Treatment in Gansu[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):13.[doi:10.19879/j.cnki.1005-5304.202002233]
[7]刘铁钢,白辰,刘邵阳,等.基于系统药理学探究新型冠状病毒肺炎中医病机[J].中国中医药信息杂志,2020,27(11):99.[doi:10.19879/j.cnki.1005-5304.202003215]
LIU Tiegang,BAI Chen,LIU Shaoyang,et al.Exploration on TCM Pathogenesis of COVID-19 Based on Systematic Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2020,27(7):99.[doi:10.19879/j.cnki.1005-5304.202003215]
备注/Memo
基金项目：甘肃省新型冠状病毒肺炎（NCP）科技重大专项（2020年）；兰州市城关区科技计划项目（2020-1-2-4）；甘肃省高校重大疾病分子医学与中医药防治研究重点实验室NCP防治科研专项开放基金（FZYX20-6）
更新日期/Last Update:
2020-06-19